Volastra

Cell division process

Biotech

Volastra taps CSO as it looks to expand research horizons

The biotech is bringing longtime adviser Samuel Bakhoum, M.D., Ph.D., on board as its chief scientific officer.

Darren Incorvaia Oct 16, 2024 7:00am

Transparent cells with nucleus cell membrane and visible chromosomes

Mitochondrial free radicals spur micronuclear collapse in cancer

Aug 29, 2024 2:00pm

cash runway cash airplane extend deal earnings

Volastra buys clinical cancer med from Amgen, tacks on $60M

Mar 7, 2023 7:00am

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am

graphic of a man with money identifying new ideas

Arch raises nearly $3B amid cratering biotech market

Jun 29, 2022 11:15am

A sheet of paper reading venture capital

Dewpoint snags $150M for programs with Pfizer, Merck and Bayer

Feb 3, 2022 6:00am